SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 2,689.07 |
| Enterprise Value ($M) | 2,467.67 |
| Book Value ($M) | 455.94 |
| Book Value / Share | 7.64 |
| Price / Book | 5.90 |
| NCAV ($M) | 192.67 |
| NCAV / Share | 3.23 |
| Price / NCAV | 13.96 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.37 |
| Return on Assets (ROA) | -0.27 |
| Return on Equity (ROE) | -0.33 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 4.62 |
| Current Ratio | 4.96 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 345.31 |
| Assets | 608.58 |
| Liabilities | 152.64 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 312.97 |
| Operating Income | -175.90 |
| Net Income | -208.73 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -64.09 |
| Cash from Investing | -3.07 |
| Cash from Financing | 6.89 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | William Blair Investment Management, Llc | |||
| 13G | State Street Corp | |||
| 13G/A | ARK Investment Management LLC | |||
| 13G | Invesco Ltd. | 6.30 | ||
| 13G/A | Nikko Asset Management Americas, Inc. | 4.88 | -20.16 | |
| 13G/A | Sumitomo Mitsui Trust Holdings, Inc. | 4.88 | -20.16 | |
| 13G/A | Jpmorgan Chase & Co | 4.30 | -43.77 | |
| 13G/A | Artisan Partners Limited Partnership | 10.40 | 62.99 | |
| 13G/A | Vanguard Group Inc | 9.49 | -3.90 | |
| 13G/A | Fmr Llc | 0.53 | -90.04 | |
| 13G/A | BlackRock, Inc. | 10.30 | -4.29 | |
| 13G/A | Integrated Core Strategies (us) Llc | 3.20 | -40.21 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| * * * * * | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 182,031 | 1,251,029 | 14.55 | |
| 162,102 | 713,161 | 22.73 | |
| 163,597 | 815,508 | 20.06 | |
| 155,097 | 874,940 | 17.73 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| TRML – Tourmaline Bio, Inc. | TSHA – Taysha Gene Therapies, Inc. |
| TSVT – 2seventy bio, Inc. | TXMD – TherapeuticsMD, Inc. |
| TYRA – Tyra Biosciences, Inc. |
Financial data and stock pages provided by
Fintel.io